Yahoo
As the U.S. stock market experiences a downturn, with the S&P 500 on track to end its three-week winning streak, investors are keenly observing opportunities across various sectors. Penny stocks, though often associated with riskier ventures, continue to capture attention due to their potential for substantial returns when backed by strong financials and growth prospects. This article explores three penny stocks that stand out for their solid balance sheets and potential for growth, offering...
Yahoo
Two preclinical studies to be presented on OV329, a potential next-generation GABA aminotransferase inhibitor, highlighting its safety profile and lack of ocular accumulation relative to vigabatrin Findings to be presented on the effects of OV329 on elevating GABA and suppressing seizures as evaluated in the lithium-pilocarpine model of status epilepticus A study of the effect of OV350, a KCC2 direct activator, in rescuing animals from nerve agent-induced benzodiazepine-resistant refractory stat
Yahoo
Ovid Therapeutics (OVID) delivered earnings and revenue surprises of -5.26% and 15.33%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Yahoo
A Phase 1 SAD/MAD study of OV329 is progressing as planned, and based on encouraging human safety data to date, Ovid will engage regulators about adding cohorts to increase potential dosing opportunities for Phase 2 programs.A regulatory application for a Phase 1 trial of OV350, the first candidate from Ovid's KCC2 direct activator library, is expected to be filed in Q4 2024.The Company will host a KCC2 Download Day on November 13 to provide updates on Ovid's platform of KCC2 direct activators a
Finnhub
Ovid Therapeutics Corporate Presentation November 2024 © Copyright 2024 Ovid Therapeutics ...
Yahoo
As the U.S. stock market continues to rally post-election, with major indices like the S&P 500 and Nasdaq reaching record highs, investors are exploring various opportunities in different corners of the market. Penny stocks, often associated with smaller or newer companies, remain a relevant investment area despite their somewhat outdated moniker. These stocks can offer potential for growth at lower price points when backed by strong financials and fundamentals, presenting intriguing...
Current Value
$0.421 Year Return
Current Value
$0.421 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CTAS | 0.00% | $78.47B | +21.13% | 1.92% |
DRI | -<0.01% | $23.31B | +21.91% | 2.76% |
CENX | -<0.01% | $1.86B | +58.85% | 0.00% |
LPG | -0.01% | $999.06M | -31.55% | 0.00% |
SWX | 0.01% | $5.46B | +5.88% | 3.27% |
TRV | -0.03% | $58.84B | +14.77% | 1.62% |
LAKE | -0.05% | $180.47M | +21.48% | 0.64% |
AVPT | 0.06% | $3.04B | +87.67% | 0.00% |
FARM | 0.08% | $46.12M | -36.28% | 0.00% |
PAYX | -0.09% | $52.29B | +18.72% | 2.72% |
FNV | -0.09% | $29.95B | +33.36% | 0.95% |
BPT | -0.10% | $12.41M | -75.73% | 0.00% |
BF.A | -0.12% | $16.19B | -35.20% | 2.60% |
MNOV | -0.13% | $74.06M | +6.34% | 0.00% |
K | -0.15% | $28.42B | +46.73% | 2.76% |
ABBV | 0.15% | $374.18B | +19.41% | 2.97% |
ECL | -0.16% | $71.30B | +10.10% | 0.97% |
KO | -0.16% | $300.00B | +15.28% | 2.83% |
ATUS | 0.17% | $1.24B | +2.69% | 0.00% |
HON | -0.18% | $136.82B | +4.72% | 2.11% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AMCX | 47.54% | $322.63M | -40.91% | 0.00% |
SYRE | 46.12% | $1.09B | -54.47% | 0.00% |
IMNM | 33.70% | $733.28M | -64.13% | 0.00% |
INNV | 32.76% | $439.54M | -34.87% | 0.00% |
ARCT | 31.31% | $348.22M | -61.24% | 0.00% |
GRAL | 31.08% | $942.63M | +103.59% | 0.00% |
SPCE | 31.02% | $151.35M | -85.10% | 0.00% |
VYX | 30.88% | $1.43B | -24.49% | 0.00% |
DAWN | 30.18% | $844.29M | -44.69% | 0.00% |
BEAM | 29.42% | $2.28B | -34.56% | 0.00% |
DNTH | 29.09% | $656.64M | -26.84% | 0.00% |
RGNX | 28.86% | $418.72M | -62.84% | 0.00% |
CARM | 28.54% | $17.36M | -83.43% | 0.00% |
ZYME | 28.54% | $907.00M | +21.41% | 0.00% |
CRNX | 28.35% | $3.19B | -23.66% | 0.00% |
IDYA | 28.34% | $1.61B | -59.59% | 0.00% |
ATXS | 28.22% | $359.49M | -60.16% | 0.00% |
AEHR | 28.20% | $266.22M | -39.74% | 0.00% |
KYMR | 28.15% | $2.16B | -18.64% | 0.00% |
YMAB | 27.88% | $222.47M | -70.96% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -19.43% | $392.24M | 1.43% |
VIXY | -12.05% | $195.31M | 0.85% |
MINT | -10.28% | $13.20B | 0.35% |
EQLS | -9.65% | $6.31M | 1% |
UGA | -9.48% | $85.26M | 0.97% |
CTA | -8.15% | $927.03M | 0.76% |
USDU | -8.04% | $214.47M | 0.5% |
USO | -7.95% | $891.33M | 0.6% |
OILK | -7.85% | $64.75M | 0.69% |
BNO | -7.60% | $90.64M | 1% |
DUSB | -7.09% | $1.13B | 0.15% |
DBE | -7.04% | $54.72M | 0.77% |
KMLM | -7.04% | $227.79M | 0.9% |
USL | -6.76% | $45.36M | 0.85% |
TAIL | -6.71% | $83.83M | 0.59% |
DBO | -6.59% | $190.57M | 0.77% |
TPMN | -5.97% | $33.27M | 0.65% |
CCOR | -5.03% | $63.91M | 1.18% |
SEIX | -4.61% | $335.88M | 0.57% |
COMT | -3.96% | $671.56M | 0.48% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CPRJ | 46.06% | $48.98M | 0.69% |
RSPA | 43.53% | $280.76M | 0% |
EFAA | 39.38% | $95.52M | 0% |
XBI | 36.09% | $5.66B | 0.35% |
QQA | 35.79% | $167.69M | 0% |
IBB | 33.58% | $6.06B | 0.45% |
GNOM | 32.74% | $57.10M | 0.5% |
ARKG | 31.82% | $1.07B | 0.75% |
XPH | 30.06% | $158.65M | 0.35% |
CPSJ | 29.41% | $33.01M | 0.69% |
IWC | 29.33% | $845.76M | 0.6% |
PBE | 29.16% | $240.72M | 0.58% |
PINK | 28.75% | $145.31M | 0.5% |
FBT | 28.29% | $1.12B | 0.56% |
BBH | 27.60% | $400.47M | 0.35% |
PBD | 27.07% | $73.79M | 0.75% |
QCLN | 26.85% | $421.22M | 0.59% |
ACES | 26.60% | $88.58M | 0.55% |
PBW | 26.53% | $236.09M | 0.65% |
BTC | 26.42% | $3.28B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MIRM | -27.35% | $2.35B | +83.83% | 0.00% |
XPOF | -19.38% | $294.26M | -41.63% | 0.00% |
KNOP | -16.02% | $215.17M | +18.57% | 1.67% |
CBOE | -14.15% | $22.97B | +19.12% | 1.11% |
VHC | -12.36% | $35.27M | +26.25% | 0.00% |
KVUE | -10.93% | $44.70B | +12.94% | 3.50% |
HMST | -10.87% | $169.53M | -41.32% | 0.00% |
STNG | -10.05% | $2.11B | -42.26% | 3.82% |
SUN | -9.89% | $7.88B | -7.20% | 6.06% |
MCK | -9.85% | $83.51B | +24.74% | 0.41% |
NOC | -9.71% | $70.82B | +4.65% | 1.68% |
WRB | -8.55% | $24.11B | +13.26% | 0.57% |
PGR | -8.50% | $160.98B | +33.59% | 1.79% |
CME | -7.74% | $96.05B | +23.35% | 3.94% |
MKC | -7.53% | $21.64B | +16.15% | 2.13% |
AJG | -7.53% | $85.18B | +33.62% | 0.73% |
KDP | -7.20% | $45.36B | +13.02% | 2.66% |
TSN | -6.81% | $21.10B | +4.05% | 3.28% |
CL | -6.55% | $73.27B | +1.70% | 2.22% |
CLX | -6.48% | $17.90B | -1.57% | 3.34% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FLOT | <0.01% | $8.91B | 0.15% |
GBIL | -0.08% | $6.15B | 0.12% |
USFR | 0.13% | $18.45B | 0.15% |
EPOL | -0.29% | $327.47M | 0.6% |
IYK | -0.34% | $1.43B | 0.4% |
BSMW | 0.41% | $101.79M | 0.18% |
IBD | 0.50% | $382.38M | 0.44% |
SHYD | 0.55% | $319.79M | 0.35% |
BUXX | 0.84% | $229.45M | 0.25% |
MSOS | 0.88% | $368.21M | 0.83% |
IAK | -0.90% | $795.67M | 0.39% |
IVOL | 0.95% | $459.41M | 1.02% |
FLRN | 1.07% | $2.77B | 0.15% |
JMST | 1.16% | $3.53B | 0.18% |
UUP | -1.29% | $332.64M | 0.77% |
IBND | 1.34% | $181.91M | 0.5% |
TBIL | 1.47% | $5.28B | 0.15% |
CGSM | -1.52% | $627.01M | 0.25% |
XLP | 1.62% | $16.37B | 0.09% |
SHLD | 1.75% | $1.24B | 0.5% |